4//SEC Filing
McLoughlin Dennis 4
Accession 0001209191-22-035225
CIK 0001396814other
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 7:31 PM ET
Size
9.8 KB
Accession
0001209191-22-035225
Insider Transaction Report
Form 4
McLoughlin Dennis
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-06-08+19,900→ 19,900 totalExercise: $59.39Exp: 2032-06-08→ Common Stock (19,900 underlying) - Award
Common Stock
2022-06-08+7,950→ 39,770 total - Sale
Common Stock
2022-06-06$61.37/sh−2,140$131,340→ 31,820 total
Footnotes (4)
- [F1]Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
- [F2]Includes 258 and 161 shares of common stock acquired under the issuer's employee stock purchase plan in June 2021 and December 2021, respectively.
- [F3]Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2023, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
- [F4]The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.
Documents
Issuer
Pacira BioSciences, Inc.
CIK 0001396814
Entity typeother
Related Parties
1- filerCIK 0001752004
Filing Metadata
- Form type
- 4
- Filed
- Jun 7, 8:00 PM ET
- Accepted
- Jun 8, 7:31 PM ET
- Size
- 9.8 KB